Key Takeaways Sustained demand, innovative product launches, and emerging market expansion are supporting broad organic growth and increasing ConvaTec's international customer base. Strong R&D investment, diversification into biologics, and cost efficiency programs are driving margin improvements, operational leverage, and resilience amid reimbursement changes.